Post by: Davmic on November 02, 2018, 01:36:38 PM
AbbVie Inc beat Wall Street estimates for third-quarter profit on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica, and the drugmaker raised its 2018 earnings forecast, sending its shares up 4 percent.
Source: AbbVie lifts profit target after cancer drug powers quarterly beat (http://feeds.reuters.com/~r/reuters/businessNews/~3/gF0zH5sMuZg/abbvie-lifts-profit-target-after-cancer-drug-powers-quarterly-beat-idUSKCN1N719Q)